Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Fresh Del Monte Produce And 2 Other Stocks Insiders Are Buying

Published 01/06/2022, 13:22
Updated 01/06/2022, 14:10
© Reuters.  Fresh Del Monte Produce And 2 Other Stocks Insiders Are Buying

Although the Dow Jones dropped more than 200 points on Tuesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Kymera Therapeutics

  • The Trade: Kymera Therapeutics, Inc. (NASDAQ: KYMR) Director Mark Lampert acquired a total of 289,426 shares at at an average price of $14.34. To acquire these shares, it cost around $4.15 million.
  • What’s Happening: Kymera Therapeutics received FDA orphan drug designation for treatment of peripheral T-cell Lymphoma.
  • What Kymera Therapeutics Does: Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.
  • The Trade: Fresh Del Monte Produce Inc. (NYSE: FDP) Chairman and CEO Mohammad Abu-Ghazaleh acquired a total of 20,000 shares at an average price of $25.29. To acquire these shares, it cost around $505.75 thousand.
  • What’s Happening: The company, last month, posted upbeat quarterly sales.
  • What Fresh Del Monte Produce Does: Fresh Del Monte Produce Inc produces, markets, and distributes fresh fruit and vegetables internationally. Additionally, it prepares and distributes juices, beverages, and snacks.

Also check this: Executives Sell Around $96M Of 5 Stocks

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Insight Enterprises

  • The Trade: Insight Enterprises, Inc. (NASDAQ: NSIT) Director Valueact Holdings GP Llc bought a total of 80,000 shares at an average price of $98.63. To acquire these shares, it cost around $7.89 million.
  • What’s Happening: The company, last month, posted upbeat quarterly results.
  • What Insight Enterprises Does: Insight Enterprises Inc is a Fortune 500 global IT provider primarily engaged in helping businesses of all sizes, large enterprises, governments, schools, and health care organizations.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.